<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">fcmedicine</journal-id><journal-title-group><journal-title xml:lang="ru">Фундаментальная и клиническая медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Fundamental and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2500-0764</issn><issn pub-type="epub">2542-0941</issn><publisher><publisher-name>КемГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23946/2500-0764-2026-11-2-125-135</article-id><article-id custom-type="elpub" pub-id-type="custom">fcmedicine-1210</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭПИДЕМИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EPIDEMIOLOGY</subject></subj-group></article-categories><title-group><article-title>Распространенность и факторы, ассоциированные с метаболическим синдромом, у госпитализированных пациентов: результаты поперечного исследования</article-title><trans-title-group xml:lang="en"><trans-title>Prevalence and associated facors of metabolic syndrome in hospitilized patients: a cross-sectional study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-0352-298X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чигирь</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chigir</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чигирь Александра Геннадьевна, аспирант кафедры эпидемиологии и доказательной медицины</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048</p></bio><bio xml:lang="en"><p>Dr. Alexandra G. Chigir, MD, Postgraduate Student, Department of Epidemiology and Evidence-Based Medicine, F.F. Erismann Institute of Public Health</p><p>Trubetskaya Street, 8, Building 2, Moscow, 119048</p></bio><email xlink:type="simple">chigir_a_g@student.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4146-4787</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Полибин</surname><given-names>Р. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Polibin</surname><given-names>R. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Полибин Роман Владимирович, кандидат медицинских наук, доцент кафедры эпидемиологии и доказательной медицины Института общественного здоровья им. Ф. Ф. Эрисмана</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048</p></bio><bio xml:lang="en"><p>Dr. Roman V. Polibin, MD, Cand. Sci. (Medicine), Associate Professor, Department of Epidemiology and Evidence-based Medicine, F.F. Erismann Institute of Public Health</p><p>Trubetskaya Street, 8, Building 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6531-6255</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драгомирецкая</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dragomiretskaya</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Драгомирецкая Наталья Александровна, доктор медицинских наук, доцент, профессор кафедры факультетской терапии № 2 Института клинической медицины им. Н. В. Склифосовского</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048</p></bio><bio xml:lang="en"><p>Prof. Natalia A. Dragomiretskaya, MD, Dr. Sci (Medicine), Professor, Department of Faculty Therapy № 2, N.V. Sklifosovsky Institute of Clinical Medicine</p><p>Trubetskaya Street, 8, Building 2, Moscow, 119048</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Московский государственный медицинский университет имени И.М. Сеченова (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>24</day><month>06</month><year>2026</year></pub-date><volume>11</volume><issue>2</issue><fpage>125</fpage><lpage>135</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чигирь А.Г., Полибин Р.В., Драгомирецкая Н.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Чигирь А.Г., Полибин Р.В., Драгомирецкая Н.А.</copyright-holder><copyright-holder xml:lang="en">Chigir A.G., Polibin R.V., Dragomiretskaya N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://fcm.kemsmu.ru/jour/article/view/1210">https://fcm.kemsmu.ru/jour/article/view/1210</self-uri><abstract><p>Цель. Оценить распространенность МС и выявить факторы, ассоциированные с его наличием, у госпитализированных пациентов.Материалы и методы. Выполнено наблюдательное выборочное аналитическое поперечное исследование с участием 187 пациентов терапевтического отделения Университетской клинической больницы № 4 Клинического центра Сеченовского Университета (период проведения исследования – с апреля 2024 г. по январь 2025 г.). Сбор данных включал ретроспективный анализ историй болезни и очное анкетирование. Сформирована группа из 84 участников с проявлениями МС и группа из 103 участников без МС. Сравнение частот встречаемости признаков в группах сравнения выполнялось с использованием критерия «Хи-квадрат» Пирсона и точного теста Фишера (для малых групп). Для оценки ассоциации предполагаемых факторов риска с МС проведена логистическая регрессия с включением в модель изучаемого фактора, пола и возраста; а также многофакторный анализ с включением в модель всех выявленных факторов.Результаты. Распространенность МС среди госпитализированных пациентов составила 44,92 %. МС статистически значимо реже встречался у лиц 18−44 лет и значимо чаще среди женщин. Наиболее распространенным сочетанием (у 44,85 % пациентов группы) было абдоминальное ожирение в сочетании с двумя дополнительными критериями. По результатам логистической регрессии и многофакторного анализа наибольшую связь с МС продемонстрировали такие факторы, как наличие гормональных нарушений у родственников 1-й степени родства (ОШ = 2,92; 95 % ДИ: 1,07–8,29; p = 0,04), употребление животных жиров и продуктов со скрытым жиром 4−5 раз в неделю (ОШ = 8,73; 95 % ДИ: 2,65–33,29; p = 0,001), а также употребление соли в количестве 5 и более г/сут. (ОШ = 3,77; 95 % ДИ: 1,24–12,31; p = 0,02).Заключение. Выявленная связь МС с наследственной предрасположенностью, избыточным употреблением жиров и соли подчеркивает необходимость качественного сбора и оценки семейного анамнеза при первичном обращении пациентов для формирования групп риска и мотивации к коррекции питания. Для подтверждения причинно-следственных связей необходимо проведение проспективных исследований в дальнейшем.</p></abstract><trans-abstract xml:lang="en"><p>Aim. To assess the prevalence of MetS and identify factors associated with its presence among hospitalized patients.Materials and methods. We conducted an observational analytical cross-sectional study on a sample of 187 patients from the therapeutic department of Sechenov University Clinical Hospital № 4 (study period: April 2024 – January 2025). Data included medical records and face-to-face interviewing. Participants were divided into two groups: 84 with MetS and 103 without. Categorical variables were compared using Pearson's chi-square and Fisher's exact tests. Logistic regression adjusted for sex and age was performed, followed by multivariate analysis.Results. The prevalence of MetS among hospitalized patients was 44.92 %. MetS was significantly less common in individuals aged 18–44 years and more prevalent among women. In the MetS group, the most common combination (44.85 % of patients) was abdominal obesity combined with two additional criteria. According to logistic regression and multivariate analysis, the factors most strongly associated with MetS were: presence of hormonal disorders in first-degree relatives (OR = 2,92; 95 % CI: 1,07–8,29; p = 0,04), consumption of animal fats and foods containing hidden fats 4–5 times per week (OR = 8,73; 95 % CI: 2,65–33,29; p = 0,001), and salt intake 5 and more g/day (OR = 3,77; 95 % CI: 1,24–12,31; p = 0,02).Conclusion. The identified association between MetS and hereditary predisposition, as well as excessive intake of fats and salt, underscores the necessity of thorough family history collection and its assessment at the patient's first visit to identify risk groups and enhance motivation for dietary correction. Further prospective studies are required to confirm causal relationships.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>метаболический синдром</kwd><kwd>семейный анамнез</kwd><kwd>распространенность</kwd><kwd>профилактика</kwd><kwd>питание</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metabolic syndrome</kwd><kwd>family history</kwd><kwd>prevalence</kwd><kwd>prevention</kwd><kwd>nutrition</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е.В., Недогода С.В., Бабенко А.Ю., Арутюнов Г.П., Драпкина О.М., Кобалава Ж.Д. и др. Концепция междисциплинарного согласительного документа по кардио-рено-гепато-метаболическому синдрому. Российский кардиологический журнал. 2025;30(1S):6533. https://doi.org/10.15829/1560-4071-2025-6533</mixed-citation><mixed-citation xml:lang="en">Shlyakhto EV, Nedogoda SV, Babenko AYu, Arutyunov GP, Drapkina OM, Kobalava ZhD, et al. Concept of an interdisciplinary consensus document on cardiovascular-renal-hepatic-metabolic syndrome. Russian Journal of Cardiology. 2025;30(1S):6533. (In Russ.). https:// doi.org/10.15829/1560-4071-2025-6533</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Islam M.S., Wei P., Suzauddula M., Nime I., Feroz F., Acharjee M., et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol. Med. 2024;30(1):279. https://doi.org/10.1186/s10020-024-01019-y</mixed-citation><mixed-citation xml:lang="en">Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, et al. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med. 2024;30(1):279. https://doi.org/10.1186/s10020-024-01019-y</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Chew N.W.S., Mehta A., Goh R., Koh J., Chen Y., Chong B., et al. The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nat. Rev. Cardiol. 2026;23(4):219–238. https://doi.org/10.1038/s41569-025-01220-4</mixed-citation><mixed-citation xml:lang="en">Chew NWS, Mehta A, Goh R, Koh J, Chen Y, Chong B, et al. The global cardiovascular-liver-metabolic syndemic: epidemiology, trends and challenges. Nat Rev Cardiol. 2026;23(4):219–238. https://doi.org/10.1038/s41569-025-01220-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Баланова Ю.А., Имаева А.Э., Куценко В.А., Капустина А.В., Муромцева Г.А., Евстифеева С.Е. и др. Метаболический синдром и его ассоциации с социально-демографическими и поведенческими факторами риска в российской популяции 25−64 лет. Кардиоваскулярная терапия и профилактика. 2020;19(4):2600. https://doi.org/10.15829/1728-8800-2020-2600</mixed-citation><mixed-citation xml:lang="en">Balanova YuA, Imaeva AE, Kutsenko VA, Kapustina AV, Muromtseva GA, Evstifeeva SE, et al. Metabolic syndrome and its associations with socio-demographic and behavioral risk factors in the Russian population aged 25-64 years. Cardiovascular Therapy and Prevention. 2020;19(4):2600. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2600</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Гринштейн Ю.И., Шабалин В.В., Руф Р.Р., Шальнова С.А. Распространенность метаболического синдрома в популяции Красноярского края и особенности его ассоциации с гиперурикемией. Российский кардиологический журнал. 2020;25(6):3852. https://doi.org/10.15829/1560-4071-2020-3852</mixed-citation><mixed-citation xml:lang="en">Grinshtein YuI, Shabalin VV, Ruf RR, Shalnova SA. The prevalence of metabolic syndrome in the Krasnoyarsk Krai population and the features of its association with hyperuricemia. Russian Journal of Cardiology. 2020;25(6):3852. (In Russ.). https://doi.org/10.15829/1560-4071-2020-3852</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mendoza-Caamal E.C., Barajas-Olmos F., García-Ortiz H., Cicerón- Arellano I., Martínez-Hernández A., Córdova E.J., et al. Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study. BMC Public Health. 2020;20(1):339. https://doi.org/10.1186/s12889-020-8378-5</mixed-citation><mixed-citation xml:lang="en">Mendoza-Caamal EC, Barajas-Olmos F, García-Ortiz H, Cicerón-Arellano I, Martínez-Hernández A, Córdova EJ, et al. Metabolic syndrome in indigenous communities in Mexico: a descriptive and cross-sectional study. BMC Public Health. 2020;20(1):339. https://doi.org/10.1186/s12889-020-8378-5</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Долич В.Н., Комлева Н.Е., Мазилов С.И., Заикина И.В. Распространенность метаболического синдрома среди работающего населения Саратовской области и его связь с медико-социальными факторами. Сибирский научный медицинский журнал. 2024;44(4):214–222. https://doi.org/10.18699/SSMJ20240425</mixed-citation><mixed-citation xml:lang="en">Dolich VN, Komleva NE, Mazilov SI, Zaikina IV. Prevalence of metabolic syndrome among the working population of the Saratov region and its relationship with medical and social factors. Sibirskij nauchnyj medicinskij zhurnal = Siberian Scientific Medical Journal. 2024;44(4):214–222. (In Russ.). https://doi.org/10.18699/SSMJ2024042</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">León-Samaniego G.F., Romero Urréa H.E., Espinoza-Carrasco F., Llimaico Noriega M.J., Encalada Campos G.E., Herrera P., et al. Metabolic Syndrome Indicators and Cardiovascular/Endocrine Risks in Rural Ecuador: A Cross-Sectional Study. J. Pers. Med. 2025;15(3):78. https://doi.org/10.3390/jpm15030078</mixed-citation><mixed-citation xml:lang="en">León-Samaniego GF, Romero Urréa HE, Espinoza-Carrasco F, Llimaico Noriega MJ, Encalada Campos GE, Herrera P, et al. Metabolic Syndrome Indicators and Cardiovascular/Endocrine Risks in Rural Ecuador: A Cross-Sectional Study. J Pers Med. 2025;15(3):78. https://doi.org/10.3390/jpm15030078</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bestavashvili A., Glazachev O., Bestavashvili A., Suvorov A., Zhang Y., Zhang X., et al. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines. 2022;10(3):566. https://doi.org/10.3390/biomedicines10030566</mixed-citation><mixed-citation xml:lang="en">Bestavashvili A, Glazachev O, Bestavashvili A, Suvorov A, Zhang Y, Zhang X, et al. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines. 2022;10(3):566. https://doi.org/10.3390/biomedicines10030566</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Sun Y., Wu H., Yang P., Huang X., Zhang L., et al. Metabolic syndromes increase significantly with the accumulation of bad dietary habits. J. Nutr. Health Aging. 2024;28(2):100017. https://doi.org/10.1016/j.jnha.2023.100017</mixed-citation><mixed-citation xml:lang="en">Li Y, Sun Y, Wu H, Yang P, Huang X, Zhang L, et al. Metabolic syndromes increase significantly with the accumulation of bad dietary habits. J Nutr Health Aging. 2024;28(2):100017. https://doi.org/10.1016/j.jnha.2023.100017</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Королев А.А., Лопухова И.В., Никитенко Е.И., Денисова Е.Л., Кирпиченкова Е.В., Онищенко Г.Г. Гигиеническая оценка поступления с рационом насыщенных жирных кислот и трансизомеров жирных кислот. Гигиена и санитария. 2024;103(6):571–576. https://doi.org/10.47470/0016-9900-2024-103-6-571-576</mixed-citation><mixed-citation xml:lang="en">Korolev AA, Lopukhova IV, Nikitenko EI, Denisova EL, Kirpichenkova EV, Onishchenko GG. Hygienic assessment of dietary intake of saturated fatty acids and trans isomers of fatty acids. Hygiene and Sanitation. 2024;103(6):571–576. (In Russ.). https://doi.org/10.47470/0016-9900-2024-103-6-571-576</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ribeiro N.G., Lelis D.F., Molina M.D.C.B., Schmidt M.I., Duncan B.B., Griep R.H., et al. The high salt intake in adults with metabolic syndrome is related to increased waist circumference and blood pressure: the Brazilian Longitudinal Study of Adult Health study (ELSA-Brasil). Nutrition. 2023;114:112108. https://doi.org/10.1016/j.nut.2023.112108</mixed-citation><mixed-citation xml:lang="en">Ribeiro NG, Lelis DF, Molina MDCB, Schmidt MI, Duncan BB, Griep RH, et al. The high salt intake in adults with metabolic syndrome is related to increased waist circumference and blood pressure: the Brazilian Longitudinal Study of Adult Health study (ELSA-Brasil). Nutrition. 2023;114:112108. https://doi.org/10.1016/j.nut.2023.112108</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Alowfi A., Binladen S., Irqsous S., Khashoggi A., Khan M.A., Calacattawi R. Metabolic Syndrome: Prevalence and Risk Factors among Adolescent Female Intermediate and Secondary Students in Saudi Arabia. Int. J. Environ Res. Public. Health. 2021;18(4):2142. https://doi.org/10.3390/ijerph18042142</mixed-citation><mixed-citation xml:lang="en">Alowfi A, Binladen S, Irqsous S, Khashoggi A, Khan MA, Calacattawi R. Metabolic Syndrome: Prevalence and Risk Factors among Adolescent Female Intermediate and Secondary Students in Saudi Arabia. Int J Environ Res Public Health. 2021;18(4):2142. https://doi.org/10.3390/ijerph18042142</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ling S., Huang L., Lia T., Xie D., Qin X., Tian C., et al. Identification and validation of core genes associated with polycystic ovary syndrome and metabolic syndrome. Medicine (Baltimore). 2024;103(42):e40162. https://doi.org/10.1097/MD.0000000000040162</mixed-citation><mixed-citation xml:lang="en">Ling S, Huang L, Lia T, Xie D, Qin X, Tian C, et al. Identification and validation of core genes associated with polycystic ovary syndrome and metabolic syndrome. Medicine (Baltimore). 2024;103(42):e40162. https://doi.org/10.1097/MD.0000000000040162</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Киселева Е.Е., Пигарова Е.А., Мокрышева Н.Г. Эволюция оценки состава тела: от индекса массы тела до профилирования состава организма. FOCUS Эндокринология. 2023;4(2):12–18. https://doi.org/10.15829/1560-4071-2023-13 EDN: NHKQST.</mixed-citation><mixed-citation xml:lang="en">Kiseleva EV, Pigarova EA, Mokrysheva NG. The evolution of body composition assessment: from body mass index to body composition profiling. FOCUS. Endocrinology. 2023;4(2):12–18. (In Russ.). https://doi.org/10.15829/1560-4071-2023-13 EDN: NHKQST.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Sheng L., Yang G., Chai X., Zhou Y., Sun X., Xing Z. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events. Front. Endocrinol. (Lausanne). 2024;15:1323571. https://doi.org/10.3389/fendo.2024.1323571</mixed-citation><mixed-citation xml:lang="en">Sheng L, Yang G, Chai X, Zhou Y, Sun X, Xing Z. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events. Front Endocrinol (Lausanne). 2024;15:1323571. https://doi.org/10.3389/fendo.2024.1323571</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
